AbbVie, J&J Units Say Del. Judge's Rebukes Bolster Fee Bid
Pharmacyclics LLC and Janssen Biotech Inc. are urging a Delaware federal judge to grant them fees after their win in patent infringement litigation over the cancer drug Imbruvica, noting the judge...To view the full article, register now.
Already a subscriber? Click here to view full article